Data as of Aug 25, 2026 · Based on 1,859 AI responses · See how Parse measures this
Online Health Products & Pharma Services
Parse
https://parse.gl
Wegovy currently anchors this contested weight-management and compounding niche as the most-cited solution across recent AI responses. Market volatility remains high as brands like and fight for prominence within the biopharma services category.
| # | Brand | What AI says | Mention rate |
|---|---|---|---|
| 1 | 23% | ||
| 2 | Widely noted for offering hair-loss treatments in discreet shipping packaging. | 15% | |
| 3 | A primary source for sterile compounding guidelines and clinical education. | 14% | |
| 4 | 13% | ||
| 5 | 13% | ||
| 6 | 13% | ||
| 7 | Frequently cited alongside semaglutide for effective appetite suppression and weight management. | 12% | |
| 8 | 12% | ||
| 9 | 11% | ||
| 10 | Regularly recommended for compounding training and pharmacist-grade resources. | 10% | |
| 11 | 9% | ||
| 12 | 9% | ||
| 13 | 9% | ||
| 14 | Commonly suggested for patients managing emotional eating or reward-based cravings. | 9% | |
| 15 | 9% | ||
| 16 | 8% | ||
| 17 | 8% | ||
| 18 | 8% | ||
| 19 | 7% | ||
| 20 | 7% | ||
| 21 | 7% | ||
| 22 | 7% | ||
| 23 | 7% | ||
| 24 | 6% | ||
| 25 | 6% |
Who wins on each AI
The same market, seen by two models.
Sources AI cited
fda.gov is the page AI reaches for most here, cited in 17% of analyzed answers.
dipped from #3 to #8 in this ranking between Nov 2025 and Aug 2026
rose from #27 to #1 in this ranking between Nov 2025 and Aug 2026
“rarely mentioned as weight-loss tool” → “recognized as only FDA-approved OTC weight loss drug”
jumped from #63 to #3 in this ranking since late 2025
| Brand | ChatGPT Search | Google AI Mode | Comparison |
|---|---|---|---|
| 14% | 17% | ||
| 15% | 16% | ||
| 12% | 16% | ||
| 14% | 15% | ||
| 12% | 16% |
The two models disagree most about Phentermine (ChatGPT #6, Google #21) and Ro (ChatGPT #19, Google #9).
Wegovy currently anchors this contested weight-management and compounding niche as the most-cited solution across recent AI responses. Market volatility remains high as brands like Qsymia and Zepbound fight for prominence within the biopharma services category.
Across 1,859 AI responses, Amazon is mentioned most, named in 23% of them, followed by Hims (15%) and American Society of Health-System Pharmacists (ASHP) (14%).
Parse measures each brand's mention rate — the share of answers naming it — across 1,859 AI responses to this market's buyer questions. Answers are collected daily and the ranking is published weekly.
Brands enter the ranking when AI answers mention them. Parse collects answers daily and publishes the re-measured set weekly, so new brands appear as AI starts recommending them.
AI responses shifted from general NIH-based advice to specific brand recommendations, highlighting Alli and GLP-1 drugs for clinical efficacy while demoting unproven herbal fat burners.
I'm looking for proven weight loss supplements. Are there any that are actually backed by science?
AI responses shifted from general NIH-based advice to specific brand recommendations, highlighting Alli and GLP-1 drugs for clinical efficacy while demoting unproven herbal fat burners.
Which "online pharmacy" offers discreet packaging for hair loss treatments?
The consensus centers on Hims,
Keeps, and Ro, with responses emphasizing unbranded, plain-box shipping to protect patient privacy during home delivery.
The market map
Recommended by need